RedHill Biopharma (RDHL) Capital Expenditures (2012 - 2022)
RedHill Biopharma (RDHL) reported Capital Expenditures of -$22000.0 for Q3 2022, down 4.76% year-over-year from -$23100.0 in Q3 2021, and up 86.5% quarter-over-quarter from -$163000.0 in Q2 2022.
RedHill Biopharma (RDHL) Capital Expenditures (2012 - 2022) Analysis & Trends
RedHill Biopharma (RDHL) has 11 years of Capital Expenditures data on file, last reported at -$22000.0 in Q3 2022.
- Capital Expenditures for Q3 2022 came in at -$22000.0, down 4.76% year-over-year; the trailing twelve-month figure through Dec 2022 was -$198000.0 (down 72.17% YoY), and the FY2025 annual result was -$5000.0, up 44.44% from the prior year.
- Capital Expenditures grew to -$22000.0 in Q3 2022 per RDHL's latest filing, from -$163000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at -$1000.0 in Q3 2019 and troughed at -$242000.0 in Q1 2020.
- A 5-year average of -$51631.6 and a median of -$20000.0 in 2020 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2018 and 2020: Capital Expenditures jumped 98.04% in 2018, then slumped 16500.0% in 2020.
- A 5-year view of Capital Expenditures shows it stood at -$5000.0 in 2018, then sank by 560.0% to -$33000.0 in 2019, then slumped by 48.48% to -$49000.0 in 2020, then soared by 93.88% to -$3000.0 in 2021, then plunged by 633.33% to -$22000.0 in 2022.
- Business Quant data shows RDHL's Capital Expenditures at -$22000.0 in Q3 2022, -$163000.0 in Q2 2022, and -$13000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 2.04 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 8.83 Mn |
| 10 | RedHill Biopharma | 142.34 Mn | 142.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -22,000.00 |
| Sep 30, 2022 | -22,000.00 |
| Jun 30, 2022 | -163,000.00 |
| Jun 30, 2022 | -163,000.00 |
| Mar 31, 2022 | -13,000.00 |
| Mar 31, 2022 | -13,000.00 |
| Dec 31, 2021 | -3,000.00 |
| Dec 31, 2021 | -3,000.00 |
| Sep 30, 2021 | -21,000.00 |
| Sep 30, 2021 | -21,000.00 |
| Jun 30, 2021 | -3,000.00 |
| Jun 30, 2021 | -3,000.00 |
| Mar 31, 2021 | -88,000.00 |
| Mar 31, 2021 | -88,000.00 |
| Dec 31, 2020 | -49,000.00 |
| Dec 31, 2020 | -49,000.00 |
| Sep 30, 2020 | -166,000.00 |
| Sep 30, 2020 | -166,000.00 |
| Jun 30, 2020 | -20,000.00 |
| Jun 30, 2020 | -20,000.00 |